British Journal of Cancer

Papers
(The H4-Index of British Journal of Cancer is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)152
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer139
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial130
Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis129
Advancing radiomics from contrast-enhanced mammography in breast cancer125
Extruded small extracellular vesicles: splinters of circulating tumour cells may promote cancer metastasis?124
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer121
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients115
CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles115
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours99
Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach97
The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma96
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing91
Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints90
Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database88
Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom88
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?87
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma85
Correction to: EGFR/Ras-induced CCL20 production modulates the tumour microenvironment84
Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort84
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer81
Genomic ALK alterations in primary and relapsed neuroblastoma80
The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer78
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity75
Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis74
A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case–control studies73
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study73
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours73
Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value70
Metabolic adaptations in prostate cancer69
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer69
Years of life lost due to cancer in the United Kingdom from 1988 to 201769
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening69
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis68
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)67
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer67
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities67
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-365
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours65
The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis63
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers63
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate61
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition60
DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma60
Metastasis-associated fibroblasts in peritoneal surface malignancies58
Navigating therapeutic strategies: HPV classification in head and neck cancer58
Identification of increased dedifferentiation along the Prom1+ cancer cells in Müllerian adenosarcoma with sarcomatous overgrowth57
Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England56
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF2056
Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma53
Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas53
Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme53
Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner53
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study53
0.07646107673645